MATTER NO. 2026-041

M&A Indemnity

Delaware & London

2026

Meridian Biologics — Cross-Border Acquisition & Escrow Defense

Structured post-closing indemnity ring-fencing and defeated an $84M working-capital adjustment claim prior to Chancery filing.

$420M

Deal consideration advised

62% → 15%

Liability cap negotiated

Claire Aldridge · Managing Partner

LEAD COUNSEL PARTNER

Architectural chambers photography accompanying matter briefing

RECORD METADATA

MATTER NO. 2026-041

Delaware & London

Claire Aldridge · Managing Partner

Mandate & Posture

Acting as lead seller counsel in a dual-track European and Delaware share purchase, Aldridge & Vance was retained ten days before scheduled execution when buyer drafts introduced uncapped fundamental survival alongside first-dollar recovery on working-capital adjustments.

Redline Strategy & Resolution

We re-anchored survival to a single eighteen-month statutory audit cycle, instituted a 0.75% tipping basket, and separated accounting objections into expedited expert determination rather than general breach indemnity.

Post-closing challenges totaling $84M were resolved within six weeks inside the agreed escrow structure with zero balance-sheet impairment to selling shareholders.

Create a free website with Framer, the website builder loved by startups, designers and agencies.